SNPs with proven functional effect and clinical relevance for the response to the following anticancer drugs: 5-Fluorouracyl, Doxorubicin, Metothrexate, Etoposide, 6-Mercaptopurine, Azothiopurin, Thioguanine, Irinotekan are studied in this project. The high precision genotyping of these SNPs is performed on the Nanogen platform. Genotyping on the Nanogen platform involves attachment of a biotinylated PCR product to a chip coated with hydrogel enriched with streptavidin, which is addressed by a stabilizer and a fluorescent labelled probe reporting for each of the variant alleles.
Figure A. Principle of SNP detection with the Nanogen system. Genotyping involves attaching a biotinylated PCR product to a streptavidin coated chip. A fluorescent probe that reports the respective allele is addressed to the amplicon. Alternatively, the probe can be attached to the solid surface and addressed by the PCR product (click to enlarge).
Key members: Silje Nordgard og Grethe I. Grenaker Alnæs
Kramer I, Hooning MJ, Mavaddat N, Hauptmann M, Keeman R, Steyerberg EW, Giardiello D, Antoniou AC, Pharoah PDP, Canisius S, Abu-Ful Z, Andrulis IL, Anton-Culver H, Aronson KJ, Augustinsson A, Becher H, Beckmann MW, Behrens S, Benitez J, Bermisheva M, Bogdanova NV, Bojesen SE, Bolla MK, Bonanni B, Brauch Het al.(2020) Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk Am J Hum Genet(in press) DOI 10.1016/j.ajhg.2020.09.001, PubMed 33022221
Tahiri A, Tekpli X, Satheesh SV, DeWijn R, Lüders T, Bukholm IR, Hurtado A, Geisler J, Kristensen VN(2020) Loss of progesterone receptor is associated with distinct tyrosine kinase profiles in breast cancer Breast Cancer Res Treat, 183(3), 585-598 DOI 10.1007/s10549-020-05763-7, PubMed 32710281
Bergholtz H, Kumar S, Wärnberg F, Lüders T, Kristensen V, Sørlie T(2020) Comparable cancer-relevant mutation profiles in synchronous ductal carcinoma in situ and invasive breast cancer Cancer Rep (Hoboken), 3(3), e1248 DOI 10.1002/cnr2.1248, PubMed 32671987